RaySearch Laboratories AB logo

RaySearch Laboratories AB (RSLBF)

Market Closed
5 Dec, 20:00
OTC PINK OTC PINK
$
27. 61
0
0%
$
822.79M Market Cap
49 P/E Ratio
0.28% Div Yield
0 Volume
0 Eps
$ 27.61
Previous Close
Day Range
27.61 27.61
Year Range
19.09 37.36
Want to track RSLBF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days

Summary

RSLBF closed yesterday higher at $27.61, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, RSLBF stock gained 44.63%.
RSLBF pays dividends to its shareholders, with the most recent payment made on May 30, 2025. The next estimated payment will be in In 5 months on May 30, 2026 for a total of $0.282.
The last earnings report, released on Nov 07, 2025, missed the consensus estimates by -1.25%. On average, the company has fell short of earnings expectations by -0.37%, based on the last three reports. The next scheduled earnings report is due on Feb 12, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

RSLBF Chart

Similar

Osb Group Plc
$ 7
0%
Zhongyuan Bank Co. Ltd. - ADR
$ -
-
SMA Solar Technology AG
$ 40.74
0%
SMA Solar Technology AG ADR
$ 4.18
-2.11%
Gamco Investors, Inc.
$ 24.91
-0.36%
RaySearch Laboratories AB (publ) (RSLBF) Q3 2025 Earnings Call Transcript

RaySearch Laboratories AB (publ) (RSLBF) Q3 2025 Earnings Call Transcript

RaySearch Laboratories AB (publ) (OTCPK:RSLBF) Q3 2025 Earnings Call November 7, 2025 4:00 AM EST Company Participants Carolina Stromlid - Head of Investor Relations Johan Löf - Founder, CEO, President & Director Nina Grönberg Conference Call Participants Mattias Vadsten - SEB, Research Division Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division Presentation Carolina Stromlid Head of Investor Relations Good morning and a warm welcome to the presentation of RaySearch Q3 2025 Results. My name is Carolina Stromlid and I'm new Head of Investor Relations at RaySearch.

Seekingalpha | 4 weeks ago

RaySearch Laboratories AB (RSLBF) FAQ

What is the stock price today?

The current price is $27.61.

On which exchange is it traded?

RaySearch Laboratories AB is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is RSLBF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.28%.

What is its market cap?

As of today, the market cap is 822.79M.

What is the earnings per share?

The EPS is 1.73.

When is the next earnings date?

The next earnings report will release on Feb 12, 2026.

Has RaySearch Laboratories AB ever had a stock split?

No, there has never been a stock split.

RaySearch Laboratories AB Profile

Insurance Industry
Financials Sector
Dr. Johan Lof CEO
OTC PINK Exchange
SE0000135485 ISIN
Sweden Country
375 Employees
23 May 2025 Last Dividend
25 Jun 2008 Last Split
- IPO Date

Overview

RaySearch Laboratories AB (publ), headquartered in Stockholm, Sweden, is a pioneering medical technology company that specializes in developing advanced software solutions aimed at improving cancer treatment. The company operates across a broad geographical range, including the Asia-Pacific, the Middle East, the Americas, Europe, and Africa. RaySearch's commitment to innovation is reflected in its focus on creating and marketing cutting-edge treatment planning systems, oncology information systems, and other specialized software platforms designed to support the complex processes involved in radiation therapy, ensuring more effective and personalized cancer care.

Products and Services

  • RayStation - A comprehensive treatment planning system that enables precise planning of radiation therapy. Designed to optimize therapy delivery for a variety of cancer types, RayStation supports clinicians in creating effective and personalized treatment plans.
  • RayPlan - An advanced treatment planning system that offers support for a wide range of treatment planning activities. RayPlan is adept in handling plans for 3D Conformal Radiotherapy (3D-CRT), Intensity-Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), tomotherapy, and electron beam radiation therapy, ensuring versatility and precision in cancer treatment planning.
  • RayCare - An oncology information system that integrates various aspects of cancer care management. RayCare facilitates seamless communication and coordination among the care team, streamlining workflow and improving the efficiency of cancer treatment processes.
  • µ-RayStation - A specialized software platform designed for small animal irradiation research. µ-RayStation enables researchers to plan and evaluate radiation therapy with high precision, contributing to advances in cancer treatment techniques and understanding.
  • RayCommand - A treatment control system that acts as a link between the treatment machine and the treatment planning and oncology information systems. RayCommand enhances the safety and efficiency of radiation therapy by facilitating smooth operations and reliable control of treatment sessions.
  • RayIntelligence - A cloud-based oncology analytics system that leverages patient data to generate actionable insights. RayIntelligence supports data-driven decisions in cancer care, helping clinicians to optimize treatment strategies based on comprehensive analytics.

In addition to these innovative software solutions, RaySearch Laboratories AB (publ) is committed to the continuous education of its clients, offering an array of training courses related to its products. Through these offerings, RaySearch empowers healthcare professionals with knowledge and tools to achieve excellence in cancer treatment and care.

Contact Information

Address: Eugeniavägen 18C
Phone: 46 8 51 05 30 00